Thanks Frank. I am a bit divided at the moment. I would like to see the company develop as a major force in the structural heart sector (not just aortic valves) but I would also like to see an early return on my investment. For me the best result would be a massive partnership deal with one of the majors for DurAVR and ComASUR, Anteris to continue developing new innovations, and the company to return some of the deal money by way of a capital return to existing shareholders. Not too much to hope for is it?
Add to My Watchlist
What is My Watchlist?
